NCT00836888View on ClinicalTrials.gov

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Conditions
Malignant Solid Tumor
Interventions
BIOLOGICAL

ONO-4538

1mg/kg, 3mg/kg, 10mg/kg and 20mg/kg ONO-4538 infusion cohorts

Trial Locations (1)

Unknown

Kanto Region

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY